Status:
UNKNOWN
Artificial Intelligence-assisted Colonoscopy for Detection of Colon Polyps
Lead Sponsor:
Side Liu
Conditions:
Artificial Intelligence
Colonoscopy
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
All subjects shall sign informed consent before screening, and subjects shall be included according to inclusion and exclusion criteria. A total of four endoscopists were included in the study, two i...
Detailed Description
This is a prospective randomized clinical study.This study was conducted in the Endoscopy Center of the Nanfang Hospital, China. Routine bowel preparation consisted of 4 L of polyethylene glycol, give...
Eligibility Criteria
Inclusion
- Chinese population aged 18-80 years old; Patients voluntarily signed informed consent form; In accordance with the indications of colonoscopy.
Exclusion
- (IBD) history of inflammatory bowel disease; History of colorectal surgery; Previous failed colonoscopy; Polyposis syndrome; Highly suspected colorectal cancer (CRC)
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2020
Estimated Enrollment :
560 Patients enrolled
Trial Details
Trial ID
NCT04126265
Start Date
September 1 2019
End Date
August 31 2020
Last Update
January 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanfang Hospital
Guangzhou, Guangdong, China